Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-14 1:55 pm Sale | 2026-03-31 | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | Capital World Investors | 10,916,799 8.200% | -5,482,090 (-33.43%) | Filing History |
| 2026-05-14 10:19 am Purchase | 2026-03-31 | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | Capital Research Global Investors | 9,471,181 7.100% | 2,502,668 (+35.91%) | Filing History |
| 2026-05-06 11:00 am Sale | 2026-03-31 | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | FMR LLC | 14,640,525 11.000% | -2,193,570 (-13.03%) | Filing History |
| 2026-04-29 4:44 pm Purchase | 2026-03-31 | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | VANGUARD CAPITAL MANAGEMENT LLC | 7,104,536 5.350% | 7,104,536 (New Position) | Filing History |
| 2026-03-26 3:24 pm Sale | 2026-03-13 | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | VANGUARD GROUP INC | 0 0.000% | -13,056,605 (Position Closed) | Filing History |
| 2025-11-05 11:26 am Purchase | 2025-09-30 | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | FMR LLC | 16,834,095 12.800% | 2,078,491 (+14.09%) | Filing History |
| 2025-04-07 11:51 am Purchase | 2025-03-31 | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | VANGUARD GROUP INC | 13,056,605 10.030% | 1,112,710 (+9.32%) | Filing History |
| 2025-02-13 2:14 pm Purchase | 2024-12-31 | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | Capital Research Global Investors | 6,968,513 5.400% | 6,968,513 (New Position) | Filing History |
| 2024-11-12 09:50 am Purchase | 2024-11-08 | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | FMR LLC | 14,755,604 11.484% | 1,490,226 (+11.23%) | Filing History |
| 2024-11-08 10:34 am Sale | 2024-09-30 | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | Wellington Management Group LLP | 5,018,779 3.910% | -2,234,128 (-30.80%) | Filing History |
| 2024-08-12 09:40 am Purchase | 2024-08-09 | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | FMR LLC | 13,265,378 10.484% | 2,922,981 (+28.26%) | Filing History |
| 2024-07-05 10:24 am Sale | 2024-06-28 | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | BAILLIE GIFFORD & CO | 6,032,656 4.770% | -934,441 (-13.41%) | Filing History |
| 2024-02-13 4:59 pm Purchase | 2023-12-29 | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | VANGUARD GROUP INC | 11,943,895 9.520% | 436,779 (+3.80%) | Filing History |
| 2024-02-09 6:14 pm Sale | 2024-02-07 | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | Capital World Investors | 16,398,889 13.100% | -195,069 (-1.18%) | Filing History |
| 2024-02-09 08:40 am Purchase | 2023-12-29 | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | Wellington Management Group LLP | 7,252,907 5.780% | 991,265 (+15.83%) | Filing History |
| 2024-02-09 08:35 am Sale | 2024-02-08 | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | FMR LLC | 10,342,397 8.239% | -3,200,428 (-23.63%) | Filing History |
| 2024-01-29 12:18 pm Sale | 2023-12-29 | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | BAILLIE GIFFORD & CO | 6,967,097 5.550% | -2,440,774 (-25.94%) | Filing History |
| 2024-01-26 5:25 pm Sale | 2023-12-31 | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | BlackRock Inc. BLK | 8,546,557 6.800% | -119,145 (-1.37%) | Filing History |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | T. Rowe Price Associates, Inc. | 4,074,144 3.300% | -2,461,224 (-37.66%) | Filing History |
| 2023-02-13 2:49 pm Purchase | 2023-02-14 | 13G | ALYNLAM PHARMACEUTICALS INC ALNY | Capital World Investors | 16,593,958 13.500% | 3,777,181 (+29.47%) | Filing History |